tiprankstipranks
Trending News
More News >
LSL Pharma Group Inc (TSE:LSL)
:LSL
Canadian Market

LSL Pharma Group Inc (LSL) Income Statement

Compare
2 Followers

LSL Pharma Group Inc Income Statement

Last quarter (Q3 2024), LSL Pharma Group Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, LSL Pharma Group Inc's net income was $-386.00K. See LSL Pharma Group Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Jul 22Dec 21Dec 20Sep 20
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 1.65M$ ―$ 2.53M$ 943.03K$ 507.58K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -5.77M$ -70.85K$ 931.55K$ 747.58K$ 990.62K
Operating Income
$ -6.67M$ -70.85K$ -65.27K$ 564.05K$ 809.27K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -8.47M$ -74.22K$ -1.78M$ 152.47K$ 88.01K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

LSL Pharma Group Inc Earnings and Revenue History